These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34547169)

  • 1. Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model.
    Wang W; Cao Q; Tan T; Yang F; Williams JB; Yan Z
    Aging Cell; 2021 Oct; 20(10):e13456. PubMed ID: 34547169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model.
    Williams JB; Cao Q; Wang W; Lee YH; Qin L; Zhong P; Ren Y; Ma K; Yan Z
    Nat Commun; 2023 Jan; 14(1):91. PubMed ID: 36609445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
    Zheng Y; Liu A; Wang ZJ; Cao Q; Wang W; Lin L; Ma K; Zhang F; Wei J; Matas E; Cheng J; Chen GJ; Wang X; Yan Z
    Brain; 2019 Mar; 142(3):787-807. PubMed ID: 30668640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
    Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model.
    Cao Q; Kumar M; Frazier A; Williams JB; Zhao S; Yan Z
    Aging (Albany NY); 2023 Nov; 15(21):11697-11719. PubMed ID: 37925173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.
    Mazzaro N; Barini E; Spillantini MG; Goedert M; Medini P; Gasparini L
    J Neurosci; 2016 Feb; 36(7):2086-100. PubMed ID: 26888921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
    Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
    Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
    Zhong P; Cao Q; Yan Z
    J Alzheimers Dis; 2024; 98(3):1121-1131. PubMed ID: 38489190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures.
    Kazim SF; Sharma A; Saroja SR; Seo JH; Larson CS; Ramakrishnan A; Wang M; Blitzer RD; Shen L; Peña CJ; Crary JF; Shimoda LA; Zhang B; Nestler EJ; Pereira AC
    Biol Psychiatry; 2022 Feb; 91(4):346-358. PubMed ID: 34130857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
    Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
    Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice.
    Chang Y; Yao Y; Ma R; Wang Z; Hu J; Wu Y; Jiang X; Li L; Li G
    Front Neurosci; 2021; 15():620176. PubMed ID: 33642981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APPsα Rescues Tau-Induced Synaptic Pathology.
    Bold CS; Baltissen D; Ludewig S; Back MK; Just J; Kilian L; Erdinger S; Banicevic M; Rehra L; Almouhanna F; Nigri M; Wolfer DP; Spilger R; Rohr K; Kann O; Buchholz CJ; von Engelhardt J; Korte M; Müller UC
    J Neurosci; 2022 Jul; 42(29):5782-5802. PubMed ID: 35667850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
    Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
    J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy.
    Watt G; Przybyla M; Zak V; van Eersel J; Ittner A; Ittner LM; Karl T
    Neuroscience; 2020 Apr; 431():166-175. PubMed ID: 32058066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.